FDA Brief

Warning letters Drugs

FDA warning letter to

JJLBRO

High riskIssued Jun 17Posted Jun 23Center for Drug Evaluation and Research (CDER)

JJLBRO and Romvy E-Ticaret sold five male creams and sprays as unapproved new drugs on a website and Amazon.

What happened

FDA reviewed the website https://jjlbro.com/ and the company’s Amazon storefront in May 2026. FDA found five products—Men’s Foreskin Repair Gel, Size’Up Chrono Erect, Penile Health Cream, Men’s External Delayed Spray, and Men’s Penis XXL Care Cream—marketed with claims to treat phimosis or premature ejaculation and to change size, stamina, or other body functions. FDA says these are unapproved new drugs because there are no approved applications for them.

What FDA found

  1. FDA says the five products are drugs because their labeling claims they treat conditions such as phimosis or premature ejaculation or affect body functions such as size or stamina.

    FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)
  2. FDA says the products are new drugs because they are not generally recognized as safe and effective and have no FDA-approved applications.

    FD&C Act sections 201(p) and 505(a), 21 U.S.C. 321(p) and 355(a)
  3. FDA says selling or shipping these unapproved new drugs in interstate commerce violates the FD&C Act.

    FD&C Act sections 301(d) and 505(a), 21 U.S.C. 331(d) and 355(a)

What FDA wants

FDA asks the company to send a written response to FDAAdvisory@fda.hhs.gov within 15 business days of receipt, with corrective steps, steps to prevent recurrence, and supporting documents, using reference number 729873.

Who should pay attention

  • online sellers of male enhancement products
  • marketplaces hosting drug or supplement storefronts
  • brands and distributors sourcing sexual health creams and sprays

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk